ROMAN BUTLER FULLERTON & CO

Position in KRYS — Krystal Biotech, Inc.

CIK 733444 ST LOUIS, MO

Position in KRYS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$375,015

+$97,658 QoQ

Shares Held

1,009

-10.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#266

of 419 holders

Holding Since

Mar 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ROMAN BUTLER FULLERTON & CO holds $1,579,980 across 3 Biotechnology names. KRYS ranks #3 (23.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,632	$810,663
2	ARGX	Argenx SE	425	$394,302
3	KRYS	Krystal Biotech, Inc. This page	1,009	$375,015

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$375,015	1,009	-10.3%	Shares	Sole	2026-08-06
2025-12-31	$277,357	1,125	-70.9%	Shares	Sole	2026-01-26
2025-03-31	$697,220	3,867	—	Shares	Sole	2025-04-21
No filing history on record for this holder in this stock.